Skip to content

Telegraph: Medical cannabis brand Oxon smokes out fresh backers

The Telegraph speaks to Equinox about its growth plans

Medical cannabis brand Oxon is talking with investors about raising as much as $15m (£12m) as it prepares to launch a range of products in the UK and eyes a listing in London or the US.

Oxon is part of Equinox International, whose main backer is private equity firm Kingsley Capital Partners. It wants to be a “British champion” of “high-end products and brands”, according to Xan Morgan, Equinox Chief Executive.

Equinox’s other venture is a Mr Nice range of cannabis products, named after the late drugs smuggler Howard Marks and licensed from his family. Cannabis-infused Oxon products such as oils, gels and creams have been developed in partnership with research lab Oxford Antibiotic Group.

Read more here